UniProt ID | TOLIP_HUMAN | |
---|---|---|
UniProt AC | Q9H0E2 | |
Protein Name | Toll-interacting protein | |
Gene Name | TOLLIP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 274 | |
Subcellular Localization | Cytoplasm . | |
Protein Description | Component of the signaling pathway of IL-1 and Toll-like receptors. Inhibits cell activation by microbial products. Recruits IRAK1 to the IL-1 receptor complex. Inhibits IRAK1 phosphorylation and kinase activity. [PubMed: 11751856 Connects the ubiquitin pathway to autophagy by functioning as a ubiquitin-ATG8 family adapter and thus mediating autophagic clearance of ubiquitin conjugates. The TOLLIP-dependent selective autophagy pathway plays an important role in clearance of cytotoxic polyQ proteins aggregates] | |
Protein Sequence | MATTVSTQRGPVYIGELPQDFLRITPTQQQRQVQLDAQAAQQLQYGGAVGTVGRLNITVVQAKLAKNYGMTRMDPYCRLRLGYAVYETPTAHNGAKNPRWNKVIHCTVPPGVDSFYLEIFDERAFSMDDRIAWTHITIPESLRQGKVEDKWYSLSGRQGDDKEGMINLVMSYALLPAAMVMPPQPVVLMPTVYQQGVGYVPITGMPAVCSPGMVPVALPPAAVNAQPRCSEEDLKAIQDMFPNMDQEVIRSVLEAQRGNKDAAINSLLQMGEEP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATTVSTQR ------CCCEECCCC | 16.39 | 22814378 | |
6 | Phosphorylation | --MATTVSTQRGPVY --CCCEECCCCCCEE | 19.41 | - | |
13 | Phosphorylation | STQRGPVYIGELPQD CCCCCCEEEECCCCC | 13.32 | 25884760 | |
25 | Phosphorylation | PQDFLRITPTQQQRQ CCCCCCCCCCHHHHH | 17.53 | 26437602 | |
45 | Phosphorylation | QAAQQLQYGGAVGTV HHHHHHHCCCCCCCC | 26.56 | 25884760 | |
63 | Acetylation | NITVVQAKLAKNYGM EEEEEEHHHHHHHCC | 31.70 | 25953088 | |
63 | Ubiquitination | NITVVQAKLAKNYGM EEEEEEHHHHHHHCC | 31.70 | 21890473 | |
63 | Ubiquitination | NITVVQAKLAKNYGM EEEEEEHHHHHHHCC | 31.70 | 21906983 | |
66 | Ubiquitination | VVQAKLAKNYGMTRM EEEHHHHHHHCCCCC | 62.23 | 21890473 | |
66 | Ubiquitination | VVQAKLAKNYGMTRM EEEHHHHHHHCCCCC | 62.23 | 21906983 | |
68 | Phosphorylation | QAKLAKNYGMTRMDP EHHHHHHHCCCCCCC | 13.94 | - | |
71 | Phosphorylation | LAKNYGMTRMDPYCR HHHHHCCCCCCCCHH | 20.62 | - | |
76 | Phosphorylation | GMTRMDPYCRLRLGY CCCCCCCCHHHHCEE | 5.97 | - | |
83 | Phosphorylation | YCRLRLGYAVYETPT CHHHHCEEEEEECCC | 9.48 | 19534553 | |
86 | Phosphorylation | LRLGYAVYETPTAHN HHCEEEEEECCCCCC | 13.10 | 25839225 | |
96 | Malonylation | PTAHNGAKNPRWNKV CCCCCCCCCCCCCCE | 69.73 | 26320211 | |
96 | Ubiquitination | PTAHNGAKNPRWNKV CCCCCCCCCCCCCCE | 69.73 | - | |
96 | Ubiquitination | PTAHNGAKNPRWNKV CCCCCCCCCCCCCCE | 69.73 | 21890473 | |
141 | Phosphorylation | THITIPESLRQGKVE EEEECCHHHHCCCCC | 24.41 | 20068231 | |
146 | Ubiquitination | PESLRQGKVEDKWYS CHHHHCCCCCCCEEE | 33.83 | 21906983 | |
150 | Ubiquitination | RQGKVEDKWYSLSGR HCCCCCCCEEECCCC | 34.23 | 21906983 | |
150 | Ubiquitination | RQGKVEDKWYSLSGR HCCCCCCCEEECCCC | 34.23 | 21890473 | |
171 | Phosphorylation | GMINLVMSYALLPAA HHHHHHHHHHHHHHH | 10.36 | - | |
235 | Acetylation | RCSEEDLKAIQDMFP CCCHHHHHHHHHHCC | 56.62 | 90979 | |
235 | Ubiquitination | RCSEEDLKAIQDMFP CCCHHHHHHHHHHCC | 56.62 | - | |
270 | Sulfoxidation | AINSLLQMGEEP--- HHHHHHHCCCCC--- | 8.02 | 21406390 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOLIP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOLIP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOLIP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells."; Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.; J. Proteome Res. 8:3852-3861(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-83, AND MASSSPECTROMETRY. |